219 related articles for article (PubMed ID: 7760801)
1. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway.
Karnitz LM; Burns LA; Sutor SL; Blenis J; Abraham RT
Mol Cell Biol; 1995 Jun; 15(6):3049-57. PubMed ID: 7760801
[TBL] [Abstract][Full Text] [Related]
2. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf.
Sutor SL; Vroman BT; Armstrong EA; Abraham RT; Karnitz LM
J Biol Chem; 1999 Mar; 274(11):7002-10. PubMed ID: 10066754
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin.
Lu Y; Phillips CA; Trevillyan JM
Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216
[TBL] [Abstract][Full Text] [Related]
4. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate.
Pandey SK; Théberge JF; Bernier M; Srivastava AK
Biochemistry; 1999 Nov; 38(44):14667-75. PubMed ID: 10545192
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine.
Crawley JB; Williams LM; Mander T; Brennan FM; Foxwell BM
J Biol Chem; 1996 Jul; 271(27):16357-62. PubMed ID: 8663063
[TBL] [Abstract][Full Text] [Related]
7. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.
King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS
Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin.
Suga J; Yoshimasa Y; Yamada K; Yamamoto Y; Inoue G; Okamoto M; Hayashi T; Shigemoto M; Kosaki A; Kuzuya H; Nakao K
Diabetes; 1997 May; 46(5):735-41. PubMed ID: 9133538
[TBL] [Abstract][Full Text] [Related]
10. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.
Monfar M; Lemon KP; Grammer TC; Cheatham L; Chung J; Vlahos CJ; Blenis J
Mol Cell Biol; 1995 Jan; 15(1):326-37. PubMed ID: 7528328
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway.
Hawes BE; Luttrell LM; van Biesen T; Lefkowitz RJ
J Biol Chem; 1996 May; 271(21):12133-6. PubMed ID: 8647803
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts.
Takuwa N; Fukui Y; Takuwa Y
Mol Cell Biol; 1999 Feb; 19(2):1346-58. PubMed ID: 9891068
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface receptor.
Hutchcroft JE; Franklin DP; Tsai B; Harrison-Findik D; Varticovski L; Bierer BE
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8808-12. PubMed ID: 7568022
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3'-kinase and p70s6k are required for insulin but not bisperoxovanadium 1,10-phenanthroline (bpV(phen)) inhibition of insulin-like growth factor binding protein gene expression. Evidence for MEK-independent activation of mitogen-activated protein kinase by bpV(phen).
Band CJ; Posner BI
J Biol Chem; 1997 Jan; 272(1):138-45. PubMed ID: 8995239
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
[TBL] [Abstract][Full Text] [Related]
16. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase.
Truitt KE; Shi J; Gibson S; Segal LG; Mills GB; Imboden JB
J Immunol; 1995 Nov; 155(10):4702-10. PubMed ID: 7594470
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils.
Knall C; Young S; Nick JA; Buhl AM; Worthen GS; Johnson GL
J Biol Chem; 1996 Feb; 271(5):2832-8. PubMed ID: 8576262
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of p70 S6 kinase activation by phosphatidylinositol 3-kinase inhibitors.
Petritsch C; Woscholski R; Edelmann HM; Parker PJ; Ballou LM
Eur J Biochem; 1995 Jun; 230(2):431-8. PubMed ID: 7607212
[TBL] [Abstract][Full Text] [Related]
19. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line.
Karnitz LM; Sutor SL; Abraham RT
J Exp Med; 1994 Jun; 179(6):1799-808. PubMed ID: 7515100
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role of phosphatidylinositol 3-kinase in IL-4-induced germline C epsilon transcription.
Ikizawa K; Kajiwara K; Basaki Y; Koshio T; Yanagihara Y
Cell Immunol; 1996 May; 170(1):134-40. PubMed ID: 8660809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
